Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Bajorin
    Bajorin
  3. Downey
    Downey
  4. Horwitz
    Horwitz
  5. Leitao
    Leitao
  6. Rosenberg
    Rosenberg
  7. Veselis
    Veselis
  8. Yulico
    Yulico

Groups

  1. Department of Medicine (3)
  2. Gynecology Disease Management Team (2)
  3. Solid Tumor Oncology Division (2)
  4. Surgery (2)
  5. Advanced Practice Providers (1)
  6. Anesthesiology Service (1)
  7. Anesthesiology and Critical Care Medicine (1)
  8. Center for Hematologic Malignancies (1)
  9. GDMT, Medicine (1)
  10. GDMT, Surgery (1)
Search Within
  1. "Lancet"
  2. "2017"
Formats
  1. Journal Article (7)
Groups
  1. Department of Medicine (3)
  2. Gynecology Disease Management Team (2)
  3. Solid Tumor Oncology Division (2)
  4. Surgery (2)
  5. Advanced Practice Providers (1)
  6. Anesthesiology Service (1)

More Groups

People
  1. Carol Aghajanian (1)
  2. Dean Bajorin (1)
  3. Deborah Korenstein (1)
  4. Heidi Yulico (1)
  5. Jonathan Rosenberg (1)
  6. Jose Baselga (1)

More People

Years
  1. 2017 (7)
Publications
  1. Lancet (7)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Bevacizumab for advanced cervical cancer: Final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
    Journal Article

    Tewari, K. S.; Sill, M. W.; Penson, R. T.; Huang, H.; Ramondetta, L. M.; Landrum, L. M.; Oaknin, A.; Reid, T. J.; Leitao, M. M.; Michael, H. E.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): An international, open-label, randomised, phase 3, multicentre trial
    Journal Article

    Prince, H. M.; Kim, Y. H.; Horwitz, S. M.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Sanches, J. A.; Ortiz-Romero, P. L.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Evidence for overuse of medical services around the world
    Journal Article

    Brownlee, S.; Chalkidou, K.; Doust, J.; Elshaug, A. G.; Glasziou, P.; Heath, I.; Nagpal, S.; Saini, V.; Srivastava, D.; Chalmers, K.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: An international, multicentre, double-blind, randomised clinical trial
    Journal Article

    Avidan, M. S.; Maybrier, H. R.; Abdallah, A. B.; Jacobsohn, E.; Vlisides, P. E.; Pryor, K. O.; Veselis, R. A.; Grocott, H. P.; Emmert, D. A.; Rogers, E. M.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: Final analysis of the HERceptin Adjuvant (HERA) trial
    Journal Article

    Cameron, D.; Piccart-Gebhart, M. J.; Gelber, R. D.; Procter, M.; Goldhirsch, A.; de Azambuja, E.; Castro, G., Jr.; Untch, M.; Smith, I.; Gianni, L.; more...
    Lancet (2017)

    Fulltext@MSK | Save
  • Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial
    Journal Article

    Balar, A. V.; Galsky, M. D.; Rosenberg, J. E.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; more...
    Lancet (2017)

    Fulltext@MSK | Save